Skip to main content

Novel Calculator Guides Treatment Choice in Esophageal Cancer

A novel calculator can more easily identify which esophageal adenocarcinoma patients derive an overall survival benefit from neoadjuvant chemoradiation to help guide treatment choices, according to a new study.
http://www.cancernetwork.com/gastrointestinal-cancer/novel-calculator-guides-treatment-choice-esophageal-cancer

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino